Results 301 to 310 of about 412,177 (358)

Cardiovascular disease in idiopathic pulmonary fibrosis: a systematic review and meta-analysis of observational studies. [PDF]

Front Med (Lausanne)
Li Y, Tan W, Zhang Y, Cao F, Wu Z, Jiao Y, Niu J.   +6 more
europepmc   +1 more source

Current Understanding of Pulmonary Fibrosis: Pathogenesis, Diagnosis, and Therapeutic Approaches. [PDF]

Can Respir J
Cui D, Che X, An R, Li L, Cui X, Jiang L, Jin J.   +6 more
europepmc   +1 more source

Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment. [PDF]

Front Immunol
Zhang K, Yuan H, Shi L.
europepmc   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Polygenic Risk and Rare Variants in Endotypes of Idiopathic Pulmonary Fibrosis

Duckworth A, Jackson L, Green H, Khan A, Wang C, Condescu A, Hawkes G, Noth I, Martinez FJ, Raghu G, Newton CA, Moll M, Cho M, Gibbons M, Scotton CJ, Columbia Genomics Consortium, Kiryluk K, Garcia CK, Zhang D.   +18 more
europepmc   +1 more source

Idiopathic Pulmonary Fibrosis [PDF]

New England Journal of Medicine, 2018
Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative, but the disease may recur in transplanted lungs.
Poletti Venerino, Tomassetti S, Ravaglia Claudia   +2 more
openaire   +8 more sources

Some of the next articles are maybe not open access.

Related searches:

Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Immunology and Allergy Clinics of North America, 2023
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease progression is common and associated with worse outcomes.
Rachel, Strykowski, Ayodeji, Adegunsoye
openaire   +2 more sources

Idiopathic Pulmonary Fibrosis

Annual Review of Medicine, 1993
Idiopathic pulmonary fibrosis kills half of its victims within five years of diagnosis. Currently available treatment regimens are disappointing, and the incidence of the disease appears to be increasing. Newer techniques of imaging coupled with laboratory advances in molecular and cellular biology may produce new strategies for modulating the disease ...
Owen J, Dempsey, David, Miller
openaire   +3 more sources